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Abstract: The aim of this study was to investigate whether vitamin E (VitE) and selenium (Se) or VitE plus Se have any the protective
and/or augmented effects on cypermethrin (CYP)-induced oxidative stress in liver, brain, kidney and blood in rats. Rats were treated
orally with daily 50 mg/kg (~ 1/4 ED50) of CYP in corn oil for five days after administrations of VitE (100 mg/kg sc.), Se (0.1 mg/kg,
sc.) and VitE plus Se for three days. Malondialdehyde (MDA) concentrations, glutathione peroxidase (GSH-Px) and catalase (CAT)
activities were measured in tissues and blood samples. MDA concentrations in all tissues except plasma, and GSH-Px activities in liver
and erythrocytes were significantly increased, but CAT activities in all tissues except erythrocytes were decreased in CYP treated
group when compared with the control group. Treatment with VitE prior to CYP reduced sensitivity on CYP-induced oxidative stress.
The use of Se was observed to increase both MDA concentrations and antioxidant systems such as GSH-Px and CAT activities. On
the other hand, VitE plus Se caused complex alterations in the antioxidant system on the oxidative stress induced by CYP. The results
suggest that CYP can induce oxidative stress and VitE can modify CYP metabolism and play a protective role against CYP-induced
oxidative stress.
Key Words: Catalase, cypermethrin, glutathione peroxidase, lipid peroxidation, oxidative stress, selenium, vitamin E.

Ratlarda Sipermetrin Taraf›ndan Oluflturulan Oksidatif Stres Üzerine
Vitamin E ve Selenyumun Etkileri
Özet: Bu çal›flman›n amac› ratlarda karaci¤er, beyin, böbrek ve kanda sipermetrin taraf›ndan oluflturulan oksidatif stres üzerine
vitamin E, selenyum ve vitamin E ile birlikte selenyumun koruyucu ve/veya artt›r›c› etkilerinin olup olmad›¤›n› araflt›rmakt›r. Ratlara
3 gün süreyle günlük olarak vitamin E (100 mg/kg), selenyum (0,1 mg/kg) ve vitamin E ile selenyumun birlikte verilmesinden sonra
5 gün süre ile m›s›r ya¤› içinde 50 mg/kg dozunda (~1/4 ED50) sipermetrin oral yolla uyguland›. Doku ve kan örneklerinde MDA
düzeyi ile GSH-Px ve CAT aktiviteleri ölçüldü. Kontrol grubu ile karfl›laflt›r›ld›¤›nda tek bafl›na sipermetrin uygulanan grupta MDA
düzeylerinin plazma hariç tüm dokularda, GSH-Px aktivitelerinin ise karaci¤er ve plazmada artt›¤› görüldü. Buna karfl›n CAT
aktivitelerinin eritrosit hariç tüm dokularda azald›¤› belirlendi. Sipermetrinden önce vitamin E uygulamas›n›n oluflan oksitadif stresi
azaltt›¤› görüldü. Selenyumun ise hem MDA konsantrasyonlar›nda hem de GSH-Px ve CAT aktiviteleri gibi antioksidan sistemlerde
art›fllara neden oldu¤u gözlemlendi. Di¤er yandan vitamin E ile birlikte selenyumun sipermetrin taraf›ndan oluflturulan oksitatif stres
üzerine antioksidan sistemde kompleks etkilere neden oldu¤u görüldü. Sonuç olarak sipermetrinin oksitadif stres oluflturabildi¤i ve
vitamin E’nin sipermetrin metabolizmas›n› de¤ifltirerek oksidatif strese karfl› koruyucu bir rol oynayabilece¤i kanaatine var›ld›.
Anahtar Sözcükler: Katalaz, sipermetrin, glutatyon peroksidaz, lipid peroksidasyon, oksidatif stress, selenyum, vitamin E.

Introduction
Synthetic pyrethroids have emerged as a new class of
agricultural pesticides and have found wide use over
organochlorine and organophosphate pesticides.

Pyrethroid pesticides show high toxicity to a wide range
of insects, including resistant strains low toxicity to
mammals and birds and rapid biodegradability (1-3). The
pyrethroids are neurotoxins, and based on their structure
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and on toxic signs observed in the rat, may be classified
into two groups, namely type I and type II compounds.
Cypermethrin (CYP) is an important photostable type II
synthetic pyrethroid derivative of natural pyrethroids.
CYP also exhibits good insecticide action and low toxicity
in mammals (4,5). Pyrethroids are more hydrophobic
than other classes of insecticides and this feature indicates
that the site of action is biological membrane. The main
target site is neuronal sodium channels and it increases
sodium entry into the nerve cell and induces
depolarization of the nerve membrane and blocks of
nerve conduction at high concentrations. An additional
mechanism for type II pyrethroids proposed inhibition of
GABA receptors (6-8).
Abnormal production of free radicals leads to damage
of some macromolecules including proteins, lipids and
nucleic acids, and this is believed to be involved in the
etiology of many chemicals and diseases (9-11). The
induction of oxidative stress and alteration of antioxidant
system by pyrethroids in animals and fishes have been
reported. Investigators showed that lipid peroxidation in
erythrocytes increased with pyrethroid treatment and
antioxidant enzyme activities and MDA concentrations
were altered after CYP exposure in fishes (2,12-14).
Under normal conditions, excessive formation of free
radicals and concomitant damage at cellular and tissue
concentrations is controlled by cellular defense systems.
These preventive defense systems can be accomplished by
enzymatic or non-enzymatic mechanisms including VitE,
vitamin C and glutathione. The antioxidant enzymes such
as GSH-Px and CAT may also have an important function
in mitigating the toxic effects of reactive oxygen species.
The preventive effect of VitE on CYP-induced elevation of
thiobarbituric acid reactive substances (TBARS) in rat
tissues observed in some studies is in agreement with its
antioxidant activity (2,15-18). Giray et al. (19) reported
that pretreatment of rats with VitE provided significant
protection against the elevation of MDA concentrations in
cerebral and hepatic tissues, induced by CYP. Additionally,
some investigators suggested that the selective block of
tetramethrin-modified sodium channels by VitE is one of
the important mechanisms underlying VitE alleviation of
paresthesia (20,21).
Selenium, in the form of GSH-Px, plays an important
role in the protection of tissue from oxidative damage.
Aside from being an integral part of GSH-Px, Se can
antagonize the toxic effects of some chemical substances
386

(22-24). On the other hand, increases of dietary and
tissue concentration of selenium, increases in plasma and
hepatic GSH-Px activities occur, followed by ultimately
hepatic lipid peroxidation (25-30).
The aim of the present study was to determine the
protective and/or augmented effects of VitE and Se or
VitE plus Se on CYP-induced oxidative stress.

Materials and Methods
Chemicals
Technical grade cypermethrin was kindly supplied by
Novartis (Istanbul, Turkey) and had a purity of >90%.
Vitamin E (DL-α-tocopherol) and Selenium (Sodium
selenite) were obtained from Merck (Darmstadt,
Germany). NADPH, Reduced glutathione, Glutathione
reductase, Thiobarbituric acid, Fospho tungustic acide, nButanol, Hydrogen peroxide and other reagents were
purchased from Sigma (St Louis, MO, USA).
Animals and Drug Administrations
Wistar rats weighing 180-250 g were provided from
a local veterinary research institute. Rats were housed in
plastic cages under standard conditions with free access
to drinking water and basal diet. The animals were
adapted to the laboratory conditions before use and were
maintained in a room with controlled temperature (22
°C), relative humidity (60%) and 12-h light:12-h dark
cycle. CYP (10 mg/ml) were suspended in corn oil and
administered to animals by gavage at the doses of 50
mg/kg BW (~ 1/4 ED50). VitE (20mg/ml) were suspended
in corn oil and administered to animals by sc at doses of
100 mg/kg BW. Selenium (0.02 mg/ml) was dissolved in
distilled water and injected to animals at the dose of 0.1
mg/kg, sc. The doses used in this study were selected on
the basis of the reports of previous studies (2,9,15,30).
The rats were divided into five groups, each including six
animals;
Group 1: (Control group): Rats received 1 ml corn oil
orally for five days.
Group 2: This group received alone CYP orally for five
days.
Group 3: This group received CYP orally for five days
following treatment with VitE for three days.
Group 4: This group received CYP orally for five days
following treatment with Se for three days.
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Group 5: This group received CYP orally for five days
following treatment with VitE plus Se for three days.
Sample Collection and Preparation of Tissue
Homogenates
Animals in all groups were decapitated (between 9:00
and 11:00 am) 24 h after the last dose application. Blood
samples were collected into tubes containing sodium
oxalate (2%). The samples were centrifuged at 200 g for
5 min at +4 °C to separate their plasma and were kept at
–20 °C until required. After separating the plasma,
erythrocytes were washed three times with 0.9% NaCl
solution to prepare erythrocyte hemolyzates. Brain, liver
and kidney tissues were removed immediately and stored
at -20 °C until the assay. The homogenization of tissues
was carried out in Teflon-glass homogenizer with a
buffer containing 1.5% KCl to obtain 1/10 (w/v) whole
homogenate. Homogenates were centrifuged 30 min at
18,000 g at +4 0C to determine of GSH-Px and CAT
activities.
Biochemical Assays
The concentrations of MDA were determined as
preceding of lipid peroxidation. MDA concentrations of
tissue homogenates were assayed according to a modified
method of Ohkawa et al. (31) based on the reaction with
thiobarbituric acid. Plasma MDA concentrations were
measured by the modified method of Satoh (32). MDA
concentrations in plasma and tissues were expressed as
nmol/ml and nmol g tissue-1, respectively. The activities of
GSH-Px and CAT were measured as other indicators of
oxidative stress. GSH-Px activities were determined by
the procedure described by Beutler (33). The procedure
of analysis performed was based on the oxidation of
reduced glutathione peroxidase coupled to the
disappearance of NADPH by glutathione reductase
measured at 37 °C and 340 nm and were expressed as U
g Hb-1 in erythrocyte and U g protein-1 in tissue. CAT
activities were determined by measuring the
decomposition of hydrogen peroxide at 240 nm,
according to the method of Aebi (34) and were expressed
as k g Hb-1 in erythrocytes and k g protein-1 in tissues
where k is the first-order rate constant. Protein
concentrations were measured according to Lowry et al.
(35). Hemoglobin concentrations were determined
according to method of Drabkin (36).
Statistic Analysis
All results were expressed as mean ± SEM.
Comparisons control group and Group 2 and between

Group 2 and remaining groups were evaluated by oneway ANOVA followed by Dunnet’s test. The P values <
0.05 were considered significant.
Results
There was no mortality in any groups during the
experiment. Slight nervousness and abnormal gait were
noted in some rats treated with cypermethrin.
Treatment with alone CYP alone caused significant
increases in MDA concentrations of liver, brain and kidney
tissues but no change was detected in plasma when
compared with the control group. A significant decrease
was observed in MDA concentrations of liver, brain and
kidney in rats treated with VitE prior to CYP but no
significant changes were seen in plasma. When compared
with the CYP treated group, an increase was observed in
MDA concentrations of liver, brain and plasma, whereas a
decrease was seen in the kidney Se treated group. While
MDA concentrations decreased in liver, kidney, they
showed slight increases in the brain tissue in VitE plus Se
treated group (Table 1).
When compared with the control group,
administration of CYP to rats caused increases in GSH-Px
activities of liver and erythrocytes but decreases were
coincided in brain and kidney. Although a decrease was
determined in GSH-Px activities of liver and brain tissues
in rats treated with VitE prior to CYP, a significant
increase was found in kidney and erythrocyte when
compared with CYP treated group. On the other hand, an
increase was observed in GSH-Px activities of all tissues in
rats treated with Se. In the group treated with VitE plus
Se, increases in GSH-Px activities were determined in all
tissues, except erythrocytes (Table 2).
Administration of CYP caused a decrease in CAT
activities of tissues, except erythrocytes, when compared
with the control group. While a significant decrease was
observed in CAT activities of brain and erythrocytes, an
increase was found in kidney in rats treated with VitE
prior to CYP. Treatment with VitE did not affect liver
CAT activity. When compared with the CYP treated
group, an increase was observed in CAT activities of liver,
kidney and erythrocytes, whereas a decrease was seen in
brain in rats treated with Se. While CAT activities
decreased in liver and brain, they showed an increase in
the kidney, but no changes were observed in erythrocytes
in VitE plus Se treated group (Table 3).
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Table 1. Liver, brain, kidney tissues (nmol/g tissue) and plasma (nmol/ml) MDA concentrations.
Liver

Brain

Kidney

Plasma

Control (Group 1)

1.53 ± 0.13

2.08 ± 0.01

1.75 ± 0.01

12.02 ± 0.31

CYP(Group 2)

2.50 a ± 0.17

2.74 a ± 0.39

2.12 a ± 0.01

11.45 ± 0.22

VitE + CYP (Group 3)

1.87 b ± 0.12

2.03 b ± 0.01

1.80 b ± 0.01

11.36 ± 0.19

b

Se + CYP (Group 4)

2.70 ± 0.11

3.11 ± 0.12

1.83 b ± 0.01

13.63 b ± 0.22

(VitE + Se) + CYP (Group 5)

1.62 b ± 0.10

3.18 b ± 0.28

1.55 b ± 0.01

11.06 ± 0.12

Data are means ± S.E.M. of 6 rats for each group and concerning presented in same column. Statistical analysis was performed using a one-way
analysis of variance followed by Dunnet’s test.
CYP was administered at the dose of 50 mg/kg, orally in 1 ml corn oil for 5 days.
VitE was injected at the dose of 100 mg/kg s.c. in 1 ml corn oil.
Se was injected at the dose of 0.1 mg/kg s.c. in 1 ml distilled water.
a
P<0.05 (compared to controls),
b
P<0.05 (compared to the rats receiving only CYP).

Table 2. Liver, brain, kidney tissues (unit/g protein) and plasma (unit/g Hb) GSH-Px activities.

Control (Group 1)

Liver

Brain

Kidney

Erythrocyte

2.40 ± 0.54

17.21 ± 3.02

8.56 ± 1.22

31.70 ± 2.72

a

2.63 ± 0.12

CYP(Group 2)

a

8.96 ± 1.23

a

41.60 a ± 2.95

b

4.21 ± 0.77

VitE + CYP (Group 3)

2.34 ± 0.29

8.51 ± 0.37

8.93 ± 0.77

55.10 b ± 5.42

Se + CYP (Group 4)

3.43 b ± 0.10

11.08 b ± 0.31

15.85 b ± 0.59

51.70 b ± 1.70

b

b

36.20 b ± 3.03

(VitE + Se) + CYP (Group 5)

b

3.60 ± 0.27

15.00 ± 2.39

11.95 ± 0.22

Data are means ± S.E.M. of 6 rats for each group and concerning presented in same column.
Statistical analysis was performed using a one-way analysis of variance followed by Dunnet’s test.
CYP was administered at the dose of 50 mg/kg, orally in 1 ml corn oil for 5 days.
VitE was injected at the dose of 100 mg/kg s.c. in 1 ml corn oil.
Se was injected at the dose of 0.1 mg/kg s.c. in 1 ml distilled water.
a
P<0.05 (compared to controls),
b
P<0.05 (compared to the rats receiving CYP alone).

Table 3. Liver, brain, kidney tissues (k/g protein) and plasma (k/g Hb) CAT activities.
Liver

Brain

Kidney

Erythrocyte

Control (Group 1)

36.85 ± 3.55

1.15 ± 0.23

19.71 ± 1.77

42.28 ± 1.01

CYP (Group 2)

31.13 a ± 2.64

0.68 a ± 0.01

12.78 a ± 0.61

44.73 a ± 0.67

VitE + CYP (Group 3)

32.35 ± 1.30

0.09 b ± 0.01

19.95 b ± 1.23

21.16 b ± 2.87

Se + CYP (Group 4)

b

34.50 ± 0.56

0.13 ± 0.01

b

30.28 ± 1.22

50.63 b ± 3.30

(VitE + Se) + CYP (Group 5)

24.46 b ± 1.18

0.10 b ± 0.01

18.50 b ± 0.40

43.10 ± 1.61

b

Data are means ± S.E.M. of 6 rats for each group and concerning presented in same column.
Statistical analysis was performed using a one-way analysis of variance followed by Dunnet’s test.
CYP was administered at the dose of 50 mg/kg, orally in 1 ml corn oil for 5 days.
VitE was injected at the dose of 100 mg/kg s.c. in 1 ml corn oil.
Se was injected at the dose of 0.1 mg/kg s.c. in 1 ml distilled water.
a
P<0.05 (compared to controls),
b
P<0.05 (compared to the rats receiving only CYP).
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Discussion
Lipid peroxidation may be due to oxidation of
molecular oxygen to produce superoxide radicals. This
reaction is also the source of H2O2, which causes the
production of MDA by initiating the peroxidation of
unsaturated fatty acids in the membrane. Both H2O2 and
.O-2 produced highly reactive hydroxyl radical with
Haber-Weiss reaction. The hydroxyl radical can initiate
lipid peroxidation which is a free radical chain leading to
loss of membrane structure and function (2,8).
Lipid peroxidation has been shown to increase in
plasma and some tissues in CYP and other insecticides
toxicities (1,12,13,15). The increase in the
concentrations of MDA in the kidney and in the activities
of GSH-Px in the liver suggested that CYP and its
metabolites may be detoxified in these tissues (12,14).
The lipophilic characteristics of CYP indicate that the site
of action is sodium channels in the neuronal membrane
(5-7) and it accumulates mostly in fat, skin, liver and
kidney (4). In our study, the concentrations of MDA in the
liver (63.3%), brain (31.8%) and kidney (21.1%) in
alone CYP treated group were significantly higher than
the control group. The increases in the concentrations of
MDA are the indicator of CYP-induced lipid peroxidation.
El-Tawil and Abdel-Rahman (3) and Giray et al. (19)
observed that the liver can be accepted as source of GSHPx, and therefore a higher activity was found in this
organ compared to the other organs. Üner et al. (14)
reported that CYP caused an increase in GSH-Px activity
while it caused a decrease in CAT activity in the liver and
kidney of some fresh water fish species. Because GSH-Px
is found mainly in cytosol and mitochondria, it is widely
affected by xenobiotics (10,29). Investigations indicated
that mammalians have a good defense mechanism for
lipid peroxidation because it can increase the hepatic CAT
activity when needed. However, CAT is generally localized
in peroxisomes and therefore its role in the other parts of
the cell is limited. In particular, H2O2 at low concentration
is destroyed by this enzyme (2,9,14). It is possible that
pyrethroids can be transported through blood to the liver
for metabolism and may produce cellular damage in
erythrocytes (2,4,5,8). In the present study, CYP caused
an increase in GSH-Px activity in liver and erythrocytes
while it caused a decrease in CAT activity in all tissues,
except erythrocytes. Our findings are in agreement with
the observations of the above workers.

Studies carried out with antioxidants have shown that
they inhibit free radical formation. VitE has also been
used to prevent oxidative damage by interrupting the
propagation of the oxidation of polyunsaturated fatty
acids. Some investigators reported that administering
VitE may be useful in controlling the hepatotoxic effects
of insecticides and chemicals (9,15,16). Some
investigators (17,19) showed the preventive effect of
VitE against CYP-induced elevation of TBARS in rat
tissues. In addition, Flannigan et al. (20) and Song and
Narahashi (21) observed that VitE is able to reduce the
cutaneous paresthesia caused by pyrethroids. In this
study, VitE treatment decreased the MDA concentrations
in liver, brain and kidney when compared with CYP
treated group. In addition, liver and brain GSH-Px
activities and CAT activities in brain and erythrocytes
were decreased by VitE. A reasonable explanation for this
may be that although VitE is not distributed uniformly in
tissues, it can show a protective effect especially when
administered prior to CYP. These observations might also
indicate that VitE has prophylactic and therapeutic effects
on CYP-induced oxidative stress.
Some investigators (11,26,28,30) suggested that Se
toxicity is related to changes in intracellular
concentrations of reduced glutathione. As dietary and
tissue concentrations of Se increase, increases in plasma
and hepatic GSH-Px activities occur, followed by increases
in ratio of hepatic oxidized to reduce glutathione and
ultimately hepatic lipid peroxidation. Zia and Islam (27)
demonstrated that the content of TBARS was elevated
dose-dependently in striatum but its concentration was
depleted in the thalamus by sodium selenite. It was shown
that when tissue concentration of Se was increased, GSHPx activities also increase in plasma and liver. In addition,
Avanzo et al. (18) determined decreases in GSH-Px
activities in chicken fed diets deficient in Se and VitE, but
increases in CAT activity. O’Grady et al. (28) observed
that dietary Se supplementation did not affect GSH-Px
activity in the presence or absence of VitE. In the present
study, increases in MDA concentrations of liver, brain and
plasma, GSH-Px activities in all tissues, CAT activities in
liver, kidney and erythrocytes, were observed in rats
treated with Se prior to CYP administration. Especially,
alterations in GSH-Px activities are compatible with the
reports of above workers and can be explained by effects
of Se on cellular structures or its alternative effects on
enzyme activities.

389

The Effects of Vitamin E and Selenium on Cypermethrin-Induced Oxidative Stress in Rats

In conclusion, the concentrations of MDA in tissues
were observed to increase significantly in rats treated
with CYP. Treatment with VitE reduced sensitivity to
oxidative stress. However, the use of selenium prior to
CYP was observed to increase both MDA concentrations
and antioxidant systems such as GSH-Px and CAT
activities. On the other hand, VitE plus Se could cause
complex alterations in the antioxidant system and

adversely could alleviate the oxidative stress induced by
CYP.
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